Millennium Management

Millennium Management’s SAB Biotherapeutics Warrant SABSW Stock Holding History

Millennium Management’s Portfolio SABSW Stock Details SABSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.63K	Hold	62,500	–	–	﹤0.01%	5598
2025 Q4	$1.95K	Hold	62,500	–	–	﹤0.01%	5924
2025 Q3	$1.46K	Hold	62,500	–	–	﹤0.01%	5951
2025 Q2	$2.08K	Hold	62,500	–	–	﹤0.01%	5770
2025 Q1	$2.18K	Hold	62,500	–	–	﹤0.01%	5747
2024 Q4	$4.71K	Hold	62,500	–	–	﹤0.01%	5819
2024 Q3	$2.25K	Hold	62,500	–	–	﹤0.01%	5962
2024 Q2	$2.96K	Hold	62,500	–	–	﹤0.01%	5709
2024 Q1	$2.44K	Hold	62,500	–	–	﹤0.01%	6056
2023 Q4	$1.89K	Hold	62,500	–	–	﹤0.01%	5918
2023 Q3	$4.38K	Hold	62,500	–	–	﹤0.01%	5895
2023 Q2	$6.53K	Hold	62,500	–	–	﹤0.01%	5824
2023 Q1	$2K	Hold	62,500	–	–	﹤0.01%	6216
2022 Q4	$3K	Hold	62,500	–	–	﹤0.01%	6359
2022 Q3	$4K	Hold	62,500	–	–	﹤0.01%	6843
2022 Q2	$12K	Hold	62,500	–	–	﹤0.01%	6621
2022 Q1	$30K	Hold	62,500	–	–	﹤0.01%	6548
2021 Q4	$112K	Hold	62,500	–	–	﹤0.01%	6210
2021 Q3	$58K	Buy	+62,500	New	+$44.6K	﹤0.01%	6551

Other funds holding SABSW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return